Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Chou

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|December 23, 2021
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In VivoYuqi Jiang, Jie Xu, Kairui Yue, et al.
Bioorganic Chemistry|August 10, 2020
Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's diseaseFeng He, Yingying Ran, Xiaoyang Li, et al.
European Journal of Medicinal Chemistry|April 18, 2017
Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity studyXiaoyang Li, Yingjie Zhang, Yuqi Jiang, et al.
Journal of Medicinal Chemistry|April 24, 2020
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia ActivityXiaoyang Li, Yuqi Jiang, Yuri K Peterson, et al.
Journal of Medicinal Chemistry|May 12, 2020
Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant SeizuresXiaoyang Li, Richard A Himes, Lyndsey C Prosser, et al.
Iscience|September 2, 2025
A plasma metabolite-based test to detect minimal residual disease in post-surgery patients with colorectal cancerZhengran Zhou, Richard Mortensen, Peishan Hu, et al.
Leukemia|October 14, 2018
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myelomaReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Nature Communications|April 8, 2025
PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestrationSadeem Ahmad, Tao Zou, Jihee Hwang, et al.
Neuropharmacology|June 25, 2026
A Staged Zebrafish-Mouse Screening Strategy for Antiseizure Compound PrioritizationCharleston F Christie, Emmaline Bendell, Ludivine Renaud, et al.
European Journal of Endocrinology|November 18, 2024
Targeted multiplex proteomics for the development and validation of biomarkers in primary aldosteronism subtypingFangli Zhou, Yun Ding, Tao Chen, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|December 23, 2021
Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In VivoYuqi Jiang, Jie Xu, Kairui Yue, et al.
Bioorganic Chemistry|August 10, 2020
Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's diseaseFeng He, Yingying Ran, Xiaoyang Li, et al.
European Journal of Medicinal Chemistry|April 18, 2017
Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity studyXiaoyang Li, Yingjie Zhang, Yuqi Jiang, et al.
Journal of Medicinal Chemistry|April 24, 2020
Design of Hydrazide-Bearing HDACIs Based on Panobinostat and Their p53 and FLT3-ITD Dependency in Antileukemia ActivityXiaoyang Li, Yuqi Jiang, Yuri K Peterson, et al.
Journal of Medicinal Chemistry|May 12, 2020
Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant SeizuresXiaoyang Li, Richard A Himes, Lyndsey C Prosser, et al.
Iscience|September 2, 2025
A plasma metabolite-based test to detect minimal residual disease in post-surgery patients with colorectal cancerZhengran Zhou, Richard Mortensen, Peishan Hu, et al.
Leukemia|October 14, 2018
Inhibitors of the protein disulfide isomerase family for the treatment of multiple myelomaReeder M Robinson, Leticia Reyes, Ravyn M Duncan, et al.
Nature Communications|April 8, 2025
PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestrationSadeem Ahmad, Tao Zou, Jihee Hwang, et al.
Neuropharmacology|June 25, 2026
A Staged Zebrafish-Mouse Screening Strategy for Antiseizure Compound PrioritizationCharleston F Christie, Emmaline Bendell, Ludivine Renaud, et al.
European Journal of Endocrinology|November 18, 2024
Targeted multiplex proteomics for the development and validation of biomarkers in primary aldosteronism subtypingFangli Zhou, Yun Ding, Tao Chen, et al.
Pageof 10